ARVO 2022: Artificial Intelligence Can Reliably Screen for Diabetic Retinopathy
Used as a screening tool, AI software may expedite referral to ophthalmologists
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.